BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15118474)

  • 1. Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
    Jonas JB; Degenring RF; Kamppeter BA
    J Glaucoma; 2004 Jun; 13(3):261. PubMed ID: 15118474
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    J Glaucoma; 2005 Feb; 14(1):90; author reply 90. PubMed ID: 15650615
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective laser trabeculoplasty for the treatment of intraocular pressure elevation after intravitreal triamcinolone injection.
    Baser E; Seymenoglu R
    Can J Ophthalmol; 2009 Jun; 44(3):e21. PubMed ID: 19506591
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide and secondary ocular hypertension.
    Jonas J; Heatley G; Spaide R; Varma R
    J Glaucoma; 2005 Apr; 14(2):168-71. PubMed ID: 15741821
    [No Abstract]   [Full Text] [Related]  

  • 6. Late intraocular pressure rise following intravitreal triamcinolone injection.
    Williams CP; Konstantopoulos A; Rowley SA; Luff AJ
    Clin Exp Ophthalmol; 2007; 35(4):385-6. PubMed ID: 17539797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
    Yang CS; Chen MJ; Chou CK; Hsu WM
    Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment.
    Ricci F; Missiroli F; Parravano M
    Eur J Ophthalmol; 2006; 16(5):756-7. PubMed ID: 17061231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
    Chew EY; Glassman AR; Beck RW; Bressler NM; Fish GE; Ferris FL; Kinyoun JL;
    Retina; 2011 Feb; 31(2):284-9. PubMed ID: 20948459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argon laser trabeculoplasty for intractable glaucoma following intravitreal triamcinolone.
    Viola F; Morescalchi F; Staurenghi G
    Arch Ophthalmol; 2006 Jan; 124(1):133-4. PubMed ID: 16401800
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide may increase the intraocular pressure even in vitrectomized eyes after more than 3 months.
    Meyer CH; Mennel S; Schmidt JC
    Am J Ophthalmol; 2005 Oct; 140(4):766-7; author reply 767-8. PubMed ID: 16226547
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
    Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
    Clin Exp Ophthalmol; 2015 Apr; 43(3):234-8. PubMed ID: 25214011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular pressure after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring R
    Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.